This trial is active, not recruiting.

Conditions heart failure, ventricular fibrillation, ventricular tachycardia
Treatment crt-d
Sponsor University of Rome Tor Vergata
Start date August 2013
End date June 2015
Trial size 436 participants
Trial identifier NCT02606071, MPP04


The IRON-MPP is a prospective multicenter, observational registry designed to collect clinical and device data from a large cohort of HF patients treated in clinical practice with a CRT-D device with the ability to deliver Multi Point Pacing.

The purpose of the Registry is to collect data on how MPP-devices are being used by physicians in order to better understand how to improve the clinical care of patients and effectiveness of MPP therapy.

United States No locations recruiting
Other Countries No locations recruiting

Study Design

Observational model cohort
Time perspective prospective

Primary Outcomes

Left ventricular ejection fraction
time frame: 6 Months

Secondary Outcomes

Heart Failure Hospitalizations
time frame: 12 months
Appropriate device interventions
time frame: 12 months
Echocardiographic changes
time frame: 12 months
QRS Duration
time frame: Baseline and six months

Eligibility Criteria

Male or female participants at least 18 years old.

Inclusion Criteria: - Patients implanted with a St. Jude Medical CRT-D system with MPP capability Exclusion Criteria: - Patients currently participating in any other clinical investigation

Additional Information

Official title Italian Registry On Multipoint Left Ventricular
Principal investigator Giovanni Forleo
Trial information was received from ClinicalTrials.gov and was last updated in November 2015.
Information provided to ClinicalTrials.gov by University of Rome Tor Vergata.